Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas Disclosure of Research Ananlyst Annual Compliance Audit Report
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Alivus Life Sciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543322 border-img ISIN Demat INE03Q201024 border-img Book Value 245.68 border-img NSE Symbol ALIVUS border-img Div & Yield % 0.54 border-img Market Cap (₹ Cr.) 11301.56 border-img P/E 20.1 border-img EPS 45.82 border-img Face Value 2
ParticularsMar 2025
(₹)		Mar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)
INCOME :       
Sales Turnover 2386.882283.212161.222123.211885.171537.31
Excise Duty 0.000.000.000.000.000.00
Net Sales 2386.882283.212161.222123.211885.171537.31
Other Income 34.5712.0428.9614.700.8111.99
Stock Adjustments -27.3556.5784.44-41.3270.704.64
Total Income 2394.102351.822274.622096.591956.681553.94
EXPENDITURE :       
Raw Materials 1010.091025.211068.56977.96948.17668.66
Power & Fuel Cost 117.24112.46115.60100.9274.1976.75
Employee Cost 251.70258.16180.18168.72149.13142.28
Other Manufacturing Expenses 177.41163.64137.17124.04107.32108.04
Selling & Administrative Expenses 83.5864.1265.4748.1948.5042.05
Miscellaneous Expenses 36.9341.9736.3946.0137.4932.22
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 1676.951665.541603.361465.831364.801069.99
Operating Profit 717.15686.29671.25630.76591.89483.96
Interest 2.411.550.5527.9687.5533.52
Gross Profit 714.74684.74670.70602.80504.34450.44
Depreciation 60.6153.4542.0937.8833.3929.37
Profit Before Tax 654.13631.29628.61564.92470.95421.07
Tax 162.44152.21150.61137.63112.7598.54
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 6.068.1911.048.576.629.43
Reported Net Profit 485.63470.89466.96418.72351.58313.10
Extraordinary Items 4.30-0.53-0.41-0.55-0.44-0.91
Adjusted Net Profit 481.33471.42467.37419.27352.02314.01
Adjustment below Net Profit -0.25-5.46-0.29-19.50-0.530.47
P & L Balance brought forward 1291.801102.061021.35750.79399.7386.17
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.00275.69385.96128.650.000.00
P & L Balance carried down 1777.181291.801102.061021.35750.79399.73
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 250.001125.002100.001050.000.000.00
Dividend Per Share(Rs) 5.0022.5042.0021.000.000.00
Earnings Per Share-Unit Curr 39.6338.4338.1134.17358.761597.44
Earnings Per Share(Adj)-Unit Curr 39.6338.4338.1134.17358.761597.44
Book Value-Unit Curr 229.92190.35174.51167.66768.112049.45
Book Value(Adj)-Unit Curr 229.92190.35174.51167.66768.112049.45
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
imsl-img
close
refresh